Harrow Health Statistics
Total Valuation
Harrow Health has a market cap or net worth of $371.48 million. The enterprise value is $461.36 million.
| Market Cap | 371.48M |
| Enterprise Value | 461.36M |
Important Dates
The next confirmed earnings date is Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Harrow Health has 35.36 million shares outstanding. The number of shares has increased by 18.78% in one year.
| Shares Outstanding | 35.36M |
| Shares Change (YoY) | +18.78% |
| Shares Change (QoQ) | +3.33% |
| Owned by Insiders (%) | 14.59% |
| Owned by Institutions (%) | 66.70% |
| Float | 26.52M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.72 |
| Forward PS | 1.87 |
| PB Ratio | 5.00 |
| P/FCF Ratio | 148.58 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 46.35, with an EV/FCF ratio of 193.85.
| EV / Earnings | n/a |
| EV / Sales | 3.54 |
| EV / EBITDA | 46.35 |
| EV / EBIT | n/a |
| EV / FCF | 193.85 |
Financial Position
The company has a current ratio of 2.83, with a Debt / Equity ratio of 2.69.
| Current Ratio | 2.83 |
| Quick Ratio | 2.41 |
| Debt / Equity | 2.69 |
| Debt / EBITDA | 19.14 |
| Debt / FCF | 80.04 |
| Interest Coverage | -0.11 |
Financial Efficiency
Return on equity (ROE) is -51.20%.
| Return on Equity (ROE) | -51.20% |
| Return on Assets (ROA) | -9.40% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $413,311 |
| Profits Per Employee | -$77,495 |
| Employee Count | 315 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 4.55 |
Taxes
In the past 12 months, Harrow Health has paid $701,000 in taxes.
| Income Tax | 701,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.59% in the last 52 weeks. The beta is 0.50, so Harrow Health's price volatility has been lower than the market average.
| Beta (1Y) | 0.50 |
| 52-Week Price Change | -58.59% |
| 50-Day Moving Average | 11.50 |
| 200-Day Moving Average | 13.08 |
| Relative Strength Index (RSI) | 31.65 |
| Average Volume (30 Days) | 463,941 |
Short Selling Information
The latest short interest is 5.92 million, so 16.75% of the outstanding shares have been sold short.
| Short Interest | 5.92M |
| Short Previous Month | 6.12M |
| Short % of Shares Out | 16.75% |
| Short % of Float | 22.33% |
| Short Ratio (days to cover) | 9.44 |
Income Statement
In the last 12 months, Harrow Health had revenue of $130.19 million and -$24.41 million in losses. Loss per share was -$0.75.
| Revenue | 130.19M |
| Gross Profit | 90.55M |
| Operating Income | 431,000 |
| Pretax Income | -23.71M |
| Net Income | -24.41M |
| EBITDA | 9.95M |
| EBIT | -2.39M |
| Loss Per Share | -$0.75 |
Balance Sheet
The company has $82.77 million in cash and $190.50 million in debt, giving a net cash position of -$107.74 million or -$3.05 per share.
| Cash & Cash Equivalents | 82.77M |
| Total Debt | 190.50M |
| Net Cash | -107.74M |
| Net Cash Per Share | -$3.05 |
| Equity / Book Value | 70.77M |
| Book Value Per Share | 2.00 |
| Working Capital | 90.14M |
Cash Flow
In the last 12 months, operating cash flow was $3.84 million and capital expenditures -$1.46 million, giving a free cash flow of $2.38 million.
| Operating Cash Flow | 3.84M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | 2.38M |
| FCF Per Share | $0.07 |
Margins
Gross margin is 69.55%, with operating and profit margins of 0.33% and -18.75%.
| Gross Margin | 69.55% |
| Operating Margin | 0.33% |
| Pretax Margin | -18.21% |
| Profit Margin | -18.75% |
| EBITDA Margin | 7.65% |
| EBIT Margin | -1.83% |
| FCF Margin | 1.83% |
Dividends & Yields
Harrow Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.78% |
| Shareholder Yield | -18.78% |
| Earnings Yield | -6.90% |
| FCF Yield | 0.67% |
Analyst Forecast
The average price target for Harrow Health is $26.00, which is 148.09% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.00 |
| Price Target Difference | 148.09% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 28.68% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 8, 2013. It was a reverse split with a ratio of 1:5.
| Last Split Date | Feb 8, 2013 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
Harrow Health has an Altman Z-Score of 1.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.02 |
| Piotroski F-Score | 2 |